Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
DHC Mediway Technology Co., Ltd., Beijing, China.
Front Endocrinol (Lausanne). 2020 Sep 16;11:643. doi: 10.3389/fendo.2020.00643. eCollection 2020.
Some patients with acromegaly do not reach the remission standard in the short term after surgery but achieve remission without additional postoperative treatment during long-term follow-up; this phenomenon is defined as postoperative delayed remission (DR). DR may complicate the interpretation of surgical outcomes in patients with acromegaly and interfere with decision-making regarding postoperative adjuvant therapy. We aimed to develop and validate machine learning (ML) models for predicting DR in acromegaly patients who have not achieved remission within 6 months of surgery. We enrolled 306 acromegaly patients and randomly divided them into training and test datasets. We used the recursive feature elimination (RFE) algorithm to select features and applied six ML algorithms to construct DR prediction models. The performance of these ML models was validated using receiver operating characteristics analysis. We used permutation importance, SHapley Additive exPlanations (SHAP), and local interpretable model-agnostic explanation (LIME) algorithms to determine the importance of the selected features and interpret the ML models. Fifty-five (17.97%) acromegaly patients met the criteria for DR, and five features (post-1w rGH, post-1w nGH, post-6m rGH, post-6m IGF-1, and post-6m nGH) were significantly associated with DR in both the training and the test datasets. After the RFE feature selection, the XGboost model, which comprised the 15 important features, had the greatest discriminatory ability (area under the curve = 0.8349, sensitivity = 0.8889, Youden's index = 0.6842). The XGboost model showed good discrimination ability and provided significantly better estimates of DR of patients with acromegaly compared with using only the Knosp grade. The results obtained from permutation importance, SHAP, and LIME algorithms showed that post-6m IGF-1 is the most important feature in XGboost algorithm prediction and showed the reliability and the clinical practicability of the XGboost model in DR prediction. ML-based models can serve as an effective non-invasive approach to predicting DR and could aid in determining individual treatment and follow-up strategies for acromegaly patients who have not achieved remission within 6 months of surgery.
一些肢端肥大症患者在手术后短期内未达到缓解标准,但在长期随访中无需额外的术后治疗即可缓解;这种现象被定义为术后延迟缓解(DR)。DR 可能会使肢端肥大症患者的手术结果解释复杂化,并干扰术后辅助治疗的决策。我们旨在开发和验证机器学习(ML)模型,以预测术后 6 个月内未缓解的肢端肥大症患者的 DR。我们纳入了 306 例肢端肥大症患者,并将其随机分为训练数据集和测试数据集。我们使用递归特征消除(RFE)算法选择特征,并应用六种 ML 算法构建 DR 预测模型。使用受试者工作特征分析验证这些 ML 模型的性能。我们使用排列重要性、Shapley 加性解释(SHAP)和局部可解释模型不可知解释(LIME)算法来确定所选特征的重要性并解释 ML 模型。55 例(17.97%)肢端肥大症患者符合 DR 标准,在训练数据集和测试数据集中,5 个特征(术后 1w rGH、术后 1w nGH、术后 6m rGH、术后 6m IGF-1 和术后 6m nGH)与 DR 显著相关。在 RFE 特征选择后,包含 15 个重要特征的 XGboost 模型具有最大的判别能力(曲线下面积=0.8349,灵敏度=0.8889,约登指数=0.6842)。与仅使用 Knosp 分级相比,XGboost 模型具有良好的判别能力,并能更好地预测肢端肥大症患者的 DR。来自排列重要性、SHAP 和 LIME 算法的结果表明,术后 6m IGF-1 是 XGboost 算法预测中最重要的特征,这表明 XGboost 模型在 DR 预测中的可靠性和临床实用性。基于 ML 的模型可以作为预测 DR 的有效非侵入性方法,并有助于确定术后 6 个月内未缓解的肢端肥大症患者的个体化治疗和随访策略。